LAMIVUDINE and ZIDOVUDINE 150 mg/1

LAMIVUDINE and ZIDOVUDINE 150 mg/1 tablets are a combination medication used in the management of HIV infection. This oral treatment helps control the virus and improve quality of life.

LAMIVUDINE and ZIDOVUDINE 150 mg/1 tablets are primarily used in the treatment of HIV infection. This combination therapy works by reducing the amount of HIV in the body, which helps the immune system function better. It is often prescribed as part of a broader antiretroviral regimen to manage the virus and improve overall health. The medication is designed to be taken orally and is intended for long-term use under medical supervision.

Common effects of LAMIVUDINE and ZIDOVUDINE 150 mg/1 tablets may include nausea, fatigue, and headache. Some individuals might experience changes in body fat distribution or mild gastrointestinal discomfort. These effects can vary from person to person and may subside over time as the body adjusts to the medication.

LAMIVUDINE and ZIDOVUDINE 150 mg/1 tablets should be handled with care and stored as directed. It is important to follow the prescribed dosage and not to share the medication with others. Regular medical check-ups are recommended to monitor the effectiveness and any potential side effects of the treatment.

LAMIVUDINE and ZIDOVUDINE 150 mg/1 tablets may interact with other medications, including certain antiretrovirals, antibiotics, and medications that affect liver enzymes. Alcohol consumption should be avoided as it can exacerbate side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.